• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

三种剂型单次静脉注射和口服氯普噻吨后的药代动力学

Pharmacokinetics of chlorprothixene after single intravenous and oral administration of three galenic preparations.

作者信息

Bagli M, Rao M L, Höflich G, Kasper S, Langer M, Barlage U, Beneke M, Süverkrüp R, Möller H J

机构信息

Psychiatrische Klinik und Poliklinik, Rheinischen Friedrich-Wilhelms-Universität, Bonn, Germany.

出版信息

Arzneimittelforschung. 1996 Mar;46(3):247-50.

PMID:8901143
Abstract

The absolute and relative bioavailability of chlorprothixene (CAS 113-59-7, Truxal) was studied in eight healthy male volunteers with three different formulations: solution, suspension and coated tablet. An intravenous infusion and an oral aqueous solution served as references. Single doses of 100 mg were administered in a randomized complete-block design with washout periods of two weeks. Serum concentrations of chlorprothixene were assayed using a high-performance liquid chromatographic method with electrochemical detection. After a 1-h infusion period the maximum serum concentration (Cmax) of chlorprothixene was 430 +/- 81 ng/ml (mean +/- S.D.) and subsequently decreased with a terminal elimination half-life (t1/2) of 25.8 +/- 13.6 h. The total serum clearance (Cl) and the apparent volume of distribution at steady state (Vss) were 867 +/- 167 ml/min and 1035 +/- 356 l, respectively. The profiles of the chlorprothixene serum concentration vs. time and the resulting pharmacokinetic parameters were similar for all orally administered formulations. The absolute oral bioavailability of 17% of the solution indicated a marked presystemic metabolism. The bioavailability of chlorprothixene relative to the oral solution was 56.4% with the coated tablet and 67.7% with the suspension. All pharmacokinetic parameters showed wide inter-subject variations, partly attributable to the respective formulation.

摘要

在8名健康男性志愿者中,使用三种不同剂型(溶液剂、混悬剂和包衣片)研究了氯丙硫蒽(CAS 113 - 59 - 7,Truxal)的绝对生物利用度和相对生物利用度。静脉输注和口服水溶液作为对照。采用随机完全区组设计,给予单剂量100 mg,洗脱期为两周。采用高效液相色谱电化学检测法测定血清中氯丙硫蒽的浓度。在1小时输注期后,氯丙硫蒽的最大血清浓度(Cmax)为430±81 ng/ml(均值±标准差),随后下降,终末消除半衰期(t1/2)为25.8±13.6小时。总血清清除率(Cl)和稳态表观分布容积(Vss)分别为867±167 ml/min和1035±356 l。所有口服剂型的氯丙硫蒽血清浓度-时间曲线和由此得出的药代动力学参数相似。溶液剂17%的绝对口服生物利用度表明存在明显的首过代谢。相对于口服溶液,氯丙硫蒽包衣片的生物利用度为56.4%,混悬剂为67.7%。所有药代动力学参数在个体间均表现出较大差异,部分归因于各自的剂型。

相似文献

1
Pharmacokinetics of chlorprothixene after single intravenous and oral administration of three galenic preparations.三种剂型单次静脉注射和口服氯普噻吨后的药代动力学
Arzneimittelforschung. 1996 Mar;46(3):247-50.
2
Bioequivalence and absolute bioavailability of oblong and coated levomepromazine tablets in CYP2D6 phenotyped subjects.
Int J Clin Pharmacol Ther. 1995 Dec;33(12):646-52.
3
Absolute and relative bioavailability of the HMG-CoA reductase inhibitor cerivastatin.HMG-CoA还原酶抑制剂西立伐他汀的绝对生物利用度和相对生物利用度。
Int J Clin Pharmacol Ther. 1997 Jun;35(6):255-60.
4
Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 2nd communication: drops with ethanol.曲马多的药代动力学及肠内曲马多制剂的生物利用度。第二次通讯:含乙醇滴剂
Arzneimittelforschung. 1998 May;48(5):436-45.
5
Study on the absolute bioavailability of quinine and theophylline from tablets after single dose oral administration as compared to intravenous infusion in healthy male non-smoking volunteers.在健康男性非吸烟志愿者中,单次口服给药后片剂中奎宁和茶碱相对于静脉输注的绝对生物利用度研究。
Methods Find Exp Clin Pharmacol. 1994 Nov;16(9):651-60.
6
Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.400毫克阿昔洛韦的两种口服混悬剂和两种口服片剂剂型的生物利用度:在健康墨西哥成年受试者中进行的两项单剂量、开放标签、随机、两期交叉比较。
Clin Ther. 2007 Jun;29(6):1146-52. doi: 10.1016/j.clinthera.2007.06.007.
7
Diclofenac and metabolite pharmacokinetics in children.双氯芬酸及其代谢物在儿童中的药代动力学。
Paediatr Anaesth. 2004 Jun;14(6):443-51. doi: 10.1111/j.1460-9592.2004.01232.x.
8
Bioavailability of repaglinide, a novel antidiabetic agent, administered orally in tablet or solution form or intravenously in healthy male volunteers.瑞格列奈(一种新型抗糖尿病药物)以片剂或溶液形式口服给药或在健康男性志愿者中静脉给药时的生物利用度。
Int J Clin Pharmacol Ther. 1998 Dec;36(12):636-41.
9
Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 3rd Communication: suppositories.曲马多的药代动力学及肠内曲马多制剂的生物利用度。第三次通讯:栓剂
Arzneimittelforschung. 1998 Sep;48(9):889-99.
10
Pharmacokinetics of ibuprofen following a single administration of a suspension containing enteric-coated microcapsules.单次服用含肠溶微胶囊的混悬液后布洛芬的药代动力学。
Arzneimittelforschung. 1995 Aug;45(8):886-90.

引用本文的文献

1
Influence of antipsychotic medications on hyperlipidemia risk in patients with schizophrenia: evidence from a population-based cohort study and hepatic lipid homeostasis gene expression.抗精神病药物对精神分裂症患者高脂血症风险的影响:基于人群的队列研究及肝脏脂质稳态基因表达的证据
Front Med (Lausanne). 2023 Jun 22;10:1137977. doi: 10.3389/fmed.2023.1137977. eCollection 2023.
2
Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2.用于筛选抑制新型冠状病毒细胞病变效应化合物的药物再利用筛选
Front Pharmacol. 2021 Jan 25;11:592737. doi: 10.3389/fphar.2020.592737. eCollection 2020.